Skip to content

iRadimed IRMD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Merit Medical Systems logo
Merit Medical SystemsMMSI
ICU Medical logo
ICU MedicalICUI
ITG
Integer HoldingsITGR
Lumexa Imaging Holdings, Inc.
 logo
Lumexa Imaging Holdings, Inc. LMRI
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's deferred tax assets and other non-current assets?
iRadimed (IRMD) reported deferred tax assets and other non-current assets of $225K in Q1 2026.
How has iRadimed's deferred tax assets and other non-current assets changed year-over-year?
iRadimed's deferred tax assets and other non-current assets increased by 9.2% year-over-year, from $206.01K to $225K.
What is the long-term trend for iRadimed's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), iRadimed's deferred tax assets and other non-current assets has grown at a -1.8% compound annual growth rate (CAGR), from $261.99K to $239K.